MustGrow Biologics Corp.
MGROF
$0.6588
-$0.0576-8.04%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 17.71% | -71.17% | -17.24% | 417.16% | -14.10% |
| Gross Profit | 359.96% | 71.17% | 17.24% | 25,430.60% | 12.72% |
| SG&A Expenses | 9.95% | -1.45% | -3.01% | -2.93% | -18.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.41% | -24.41% | -5.63% | 15.27% | -21.29% |
| Operating Income | 6.53% | 24.41% | 5.63% | 482.66% | 21.25% |
| Income Before Tax | 11.12% | 21.53% | 0.83% | 441.68% | 15.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.12% | 21.53% | 0.83% | 441.68% | 15.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.12% | 21.53% | 0.83% | 441.68% | 15.18% |
| EBIT | 6.53% | 24.41% | 5.63% | 482.66% | 21.25% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 14.03% | 24.44% | 4.49% | 436.24% | 16.27% |
| Normalized Basic EPS | 14.37% | 24.11% | 4.12% | 436.56% | 15.94% |
| EPS Diluted | 14.03% | 24.44% | 4.49% | 436.24% | 16.27% |
| Normalized Diluted EPS | 14.37% | 24.11% | 4.12% | 436.56% | 15.94% |
| Average Basic Shares Outstanding | 3.53% | 3.91% | 3.60% | 1.32% | 1.16% |
| Average Diluted Shares Outstanding | 3.53% | 3.91% | 3.60% | 1.32% | 1.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
